Toggle menu
  • Login or Sign Up
  • 0
  • Wishlist
    • GBP
      • British Pound
      • US Dollar
  • Biopharma Research
    Reset Search ×
    • 0
    Reset Search ×
    • GBP
      • British Pound
      • US Dollar

      Main Menu

    • OUR SERVICES
      • Custom Research Services
      • Laboratory End User Surveys
    • ABOUT US
    • CONTACT US
    • Shop By Category

    • All Diagnostics Markets
    • Multiplex Diagnostics
    • Therapeutics
    • Genomics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • COVID-19 Diagnostics
    • Point of Care (POC) Diagnostics
    • Direct-to-Consumer (DTC) Diagnostics
    • Rapid Diagnostics
    • Laboratory Techniques
    • Medical Laboratory Services
    • Calibration
    • GBP
      • British Pound
      • US Dollar
    • Gift Certificates
    • Login or Sign Up

    Market ReportsMarket Reports

    Shop by Category

  • All Diagnostics Markets
  • Multiplex Diagnostics
  • Therapeutics
  • Genomics
  • Cancer Diagnostics
  • Infectious Disease Diagnostics
  • COVID-19 Diagnostics
  • Point of Care (POC) Diagnostics
  • Direct-to-Consumer (DTC) Diagnostics
  • Rapid Diagnostics
  • Laboratory Techniques
  • Medical Laboratory Services
  • Calibration

    • Main Menu

    • OUR SERVICES
      • Custom Research Services
      • Laboratory End User Surveys
    • ABOUT US
    • CONTACT US
    • Shop By Category

    • All Diagnostics Markets
    • Multiplex Diagnostics
    • Therapeutics
    • Genomics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • COVID-19 Diagnostics
    • Point of Care (POC) Diagnostics
    • Direct-to-Consumer (DTC) Diagnostics
    • Rapid Diagnostics
    • Laboratory Techniques
    • Medical Laboratory Services
    • Calibration
    Reset Search ×
    • 0
    Scientist completing multiplex testing in a laboratory.

    SYNDROMIC MULTIPLEX DIAGNOSTIC MARKETS:

    Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) and Country with Market Analysis, Executive Guides and Customization 2022 to 2026

    VIEW REPORT

    COVID-19 Diagnostics:

    Global Market Forecasts by Technology, Product, Channel, Country - Assay Volumes and Market Size Outlook to 2026 (Includes 2021 Market Share)

    VIEW REPORT
    Human immune system attacking cancer cells

    IMMUNO-ONCOLOGY DIAGNOSTICS MARKETS:

    Forecasts and Updates Including Executive/Consultant Guides with Customized Forecasting and Analysis 2022 to 2026

    VIEW REPORT
    In-vitro testing used as companion diagnostic test in cancer screening

    COMPANION DIAGNOSTICS MARKETS:

    by Funding Source and Application with Customised Forecasting and Analysis; Executive and Consultant Guides 2022 - 2026

    VIEW REPORT
    Transparent human torso highlighting the internal respiratory system

    RESPIRATORY INFECTION DIAGNOSTICS MARKETS:

    by Technology, Plex, Facility and Region: Forecasting /Analysis (Including Executive and Consultant Guides) 2022 to 2026

    VIEW REPORT
    • Cancer
      Cancer
    • Genomics
      Genomics
    • Infectious Disease
      Infectious Disease

    Featured Products

    • Monkeypox Diagnostics Markets 2022 to 2026
      Quick view

      MONKEYPOX DIAGNOSTICS: Global Markets by Assay, Country, Product and Place with Executive, Consultant Guides and Market Analysis and Forecasts 2022 – 2026

      £5,647.06 - £11,298.16
      Choose Options
    • Home Diagnostics Markets 2022 to 2026
      Quick view

      HOME DIAGNOSTICS MARKETS: Strategies and Trends, Forecasts by Application, Channel, Technology and Country with Market Analysis and Executive Guides 2022 to 2026

      £5,647.06 - £11,298.16
      Choose Options
    • Diagnostic Enzyme Markets 2022 to 2026
      Quick view

      Diagnostic Enzyme Markets: Global Market Forecasts by Product Type, Application and Country Updated for COVID-19 Pandemic Impact with Executive and Consultant Guides 2022 to 2026

      £5,647.06 - £11,298.16
      Choose Options
    • Molecular Diagnostics at the Point of Care 2022 to 2026
      Quick view

      Molecular Diagnostics at the Point of Care by Application, Technology, Place, Product and Country with COVID-19 POC Breakout and Executive Guides and Customization 2022 - 2026

      £5,647.06 - £11,298.16
      Choose Options
    • COVID-19 Diagnostics Markets 2022 to 2026
      Quick view

      COVID-19 Diagnostics: Global Market Forecasts by Technology, Product, Channel and Country - Assay Volumes & Market Size Outlook to 2026 (Includes 2021 Market Share)

      £5,647.06 - £11,298.16
      Choose Options
    • Flow Cytometry Markets 2022 to 2026
      Quick view

      Flow Cytometry Markets: Forecasts by Technology, Product and Application with Executive and Consultant Guides Including Custom Forecasting 2022 to 2026

      £5,647.06 - £11,298.16
      Choose Options
    • CRISPR Gene Detection and Diagnostic Markets 2022 to 2026
      Quick view

      CRISPR GENE DETECTION and DIAGNOSTIC MARKETS by Research, Clinical Lab, Consumer, Public Service & Other with Executive and Consultant Guides 2022 to 2026

      £5,647.06 - £11,298.16
      Choose Options
    • Analytics of the Microbiome Landscape - Front Cover
      Quick view

      Analytics of the Microbiome Landscape

      £1,412.78 - £7,265.70
      Choose Options
    • Oligonucleotide Synthesis Markets 2022 to 2026
      Quick view

      Oligonucleotide Synthesis Markets: Forecasts by Oligo Length, Application and Product with Executive and Consultant Guides Including Customized Forecasting and Analysis 2022 to 2026

      £5,647.06 - £11,298.16
      Choose Options
    • PCR Markets 2022 to 2026
      Quick view

      PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis. Updated to include impact of COVID-19 Diagnostics 2022 to 2026

      £5,647.06 - £11,298.16
      Choose Options
    • Human Gene Sequencing Markets 2022 to 2026
      Quick view

      Human Gene Sequencing Markets: Strategies and Trends, Forecasts by Application, Technology, Workflow, Product and Country with Executive and Consultant Guides 2022 to 2026

      £5,647.06 - £11,298.16
      Choose Options
    • Whole Genome and Exam Sequencing Markets to 2026
      Quick view

      Whole Genome and Exome Sequencing Markets 2022 to 2026 by Application, Organism and Product with Executive and Consultant Guides 2022 - 2026

      £5,647.06 - £11,298.16
      Choose Options
    • Molecular Diagnostics for Infectious Disease Markets 2022 to 2026
      Quick view

      Infectious Disease Molecular Diagnostics Markets by Syndrome, Plex, Facility and Country with Forecasting/Analysis, Executive Guides and Customization 2022 to 2026

      £5,647.06 - £11,298.16
      Choose Options
    • Sepsis Diagnostics Markets 2022 to 2026
      Quick view

      SEPSIS DIAGNOSTICS: Global Market Analysis and Forecasts by Assay, Cause, Product, Lab and Setting with Executive and Consultant Guides 2022 - 2026

      £5,647.06 - £11,298.16
      Choose Options
    • Immunoassay Markets 2022 - 2026
      Quick view

      Immunoassay Markets: Strategies and Trends, Volume and Price Forecasts by Instrument Type, Application and by Country with Multiplex and Point of Care Market Analysis, Executive Guides Including Customized Forecasting and Analysis 2022 - 2026

      £5,647.06 - £11,298.16
      Choose Options
    ×
    Contact Us
    Westfield House
    Millfield Lane
    Nether Poppleton
    YORK, YO26 6GA
    United Kingdom
    +44(0)1904 868857
    Accounts & Orders
    • Wishlist
    • Login or Sign Up
    • Order Status
    • Privacy Security Shipping
    Navigate
    • OUR SERVICES
    • ABOUT US
    • CONTACT US
    Join Our Mailing List

    Sign up for our newsletter to receive specials and up to date product news and releases.

    • © Biopharma Research Ltd